Dr. Lisa Bodei
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Neuroendocrine Tumors
Studies Pancreatic Neuroendocrine Tumors
8 reported clinical trials
13 drugs studied
Area of expertise
1Neuroendocrine Tumors
Stage IV
somatostatin receptor positive
Somatostatin receptor positive
2Pancreatic Neuroendocrine Tumors
Stage IV
somatostatin receptor positive
Somatostatin receptor positive
Affiliated Hospitals
Clinical Trials Lisa Bodei is currently running
RYZ101
for Neuroendocrine Tumors
This trial tests RYZ101, a new drug, in patients with advanced GEP-NETs that haven't responded to previous treatments. The drug aims to target specific receptors on the tumor cells to stop their growth.
Recruiting2 awards Phase 312 criteria
177Lu-DOTA-EB-TATE
for Neuroendocrine Cancer
This trial is testing a new targeted radiation therapy for patients with advanced or hard-to-remove GEP-NETs. The therapy uses a radioactive substance that binds to cancer cells and delivers radiation directly to them.
Recruiting1 award Phase 1
More about Lisa Bodei
Clinical Trial Related3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Lisa Bodei has experience with
- 177Lu-DOTATATE
- 177Lu-DOTA-EB-TATE
- CAM-H2
- Lutetium-based PSMA Radioligand Therapy
- Tumor Biopsy
- Blood Draw
Breakdown of trials Lisa Bodei has run
Neuroendocrine Tumors
Pancreatic Neuroendocrine Tumors
Prostate Cancer
Exacerbation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lisa Bodei specialize in?
Lisa Bodei focuses on Neuroendocrine Tumors and Pancreatic Neuroendocrine Tumors. In particular, much of their work with Neuroendocrine Tumors has involved Stage IV patients, or patients who are somatostatin receptor positive.
Is Lisa Bodei currently recruiting for clinical trials?
Yes, Lisa Bodei is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Lisa Bodei has studied deeply?
Yes, Lisa Bodei has studied treatments such as 177Lu-DOTATATE, 177Lu-DOTA-EB-TATE, CAM-H2.
What is the best way to schedule an appointment with Lisa Bodei?
Apply for one of the trials that Lisa Bodei is conducting.
What is the office address of Lisa Bodei?
The office of Lisa Bodei is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.